Hyperfine Inc (HYPR)

NASD · Healthcare · Medical Devices · USA

Hyperfine Inc is a micro cap company (market value under $300 million) in the Medical Devices industry.

Hyperfine develops the Swoop portable magnetic resonance imaging system for brain imaging across multiple healthcare settings including hospitals, clinics, and physician offices. The device uses ultra-low-field technology with artificial intelligence to provide diagnostic brain images without ionizing radiation exposure. The company serves healthcare professionals and institutions in the United States and internationally through direct sales and distributor relationships.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Hyperfine Inc stock.

Our verdict on HYPR

Overvalued: intrinsic value $0.40 per share, market price $0.56, margin of safety -40.7% (as of 2026-11-17).

A 0.9x revenue multiple, discounted for its losses, values the shares at $0.40; the price of $0.56 is 41% above that value.

ETFs with the most weight in HYPR

8 more funds hold it; the full list is part of the paid plan.

More on HYPR

Browse

Peers in Medical Devices

All 140 Medical Devices stocks

Cheaper than HYPR in Medical Devices

28 more in this industry show a wider margin of safety.

Is HYPR undervalued or overvalued?

HYPR is overvalued (as of the 2026-11-17 close). A 0.9x revenue multiple, discounted for its losses, values the shares at $0.40; the price of $0.56 is 41% above that value.

What is the intrinsic value of HYPR?

$0.40 per share (as of the 2026-11-17 close), against a market price of $0.56. That is a margin of safety of -40.7%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.